(Adds Outlook)
Zimmer Biomet Holdings, Inc. (ZBH) updated full-year 2024 financial guidance to reduce and narrow previous projected ranges for revenue growth and adjusted EPS. Adjusted EPS is now expected in a range of $7.95 - $8.05, revised from prior guidance range of $8.00 - $8.15. Reported revenue is anticipated to rise 3.5% - 4.0%, updated from previous guidance range of 4.0% - 5.0%.
Q3 Results:
The company's earnings came in at $249.1 million, or $1.23 per share. This compares with $162.7 million, or $0.77 per share, in last year's third quarter. Excluding items, adjusted earnings was $1.74 per share compared to $1.65. Analysts on average had expected the company to earn $1.73 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items. The company's revenue for the quarter rose 4.1% to $1.82 billion from $1.75 billion last year.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.
For comments and feedback contact: editorial@rttnews.com
Business News
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.